Moneycontrol PRO

you are here: HomeNewsBusinessEarningsSee Rs 20-25cr in revenue/quarter from Lanzoprazol: Natco

SHOW NAMES

Trending Topics

SBI Q1 Results Manappuram Finance Q1 Results Tata Motors Q1 results Titan Q1 Preview SBI Q1 Preview

business

See Rs 20-25cr in revenue/quarter from Lanzoprazol: Natco

Hyderabad-based Natco Pharma Limited, on December 21, received the approval from Food & Drug Administration (FDA) for marketing the prescription version of Lanzoprazole, CFO of the company Bhaskar Narayana told CNBC-TV18 in an interview.

first published: Feb 14, 2013 02:44 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347